Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
410 * !
|
Wed, 8/10/2022,
10:30 AM -
12:20 PM
|
CC-154A
|
|
Bayesian Adaptive Designs and Novel Strategies for Dose Optimization in Cellular Therapy Drug Development — Topic Contributed Papers
|
|
Biopharmaceutical Section, International Society for Bayesian Analysis (ISBA), Stats. Partnerships Among Academe Indust. & Govt. Committee
|
|
Organizer(s): Yunqi Zhao, Takeda Pharmaceutical
|
|
Chair(s): Yunqi Zhao, Takeda Pharmaceutical
|
|
10:35 AM
|
The Ji3+3 Design for Cell/Gene Therapy Dose-Finding Trials with Joint Efficacy and Toxicity Outcomes
Yuan Ji, The University of Chicago; Xiaolei Lin, Fudan University
|
|
10:55 AM
|
PMED: Optimal Bayesian Design for Platform Trials with Multiple Endpoints
Rachael Liu, Takeda Pharamaceuticals; Tian He, Indiana University Purdue University Indianapolis; Meizi Liu, Takeda pharmaceuticals; Jianchang Lin, Takeda Pharmaceuticals
|
|
11:15 AM
|
A Sequential Basket Trial Design Based on Multi-Source Exchangeability with Predictive Probability Monitoring
Alexander Kaizer, University of Colorado Anschutz Medical Campus; Emily Zabor, Cleveland Clinic; Lei Nie, U. S. FDA; Brian P Hobbs, The University of Texas
|
|
11:35 AM
|
GBOIN-ET: A Generalized Bayesian Optimal Interval Design for Optimal Dose-Finding Accounting for Ordinal Graded Efficacy and Toxicity in Early Clinical Trials
Kentaro Takeda, Astellas Pharma Global Development, Inc.
|
|
11:55 AM
|
Discussant: Shuqi Wang, Georgetown University
|
|
12:15 PM
|
Floor Discussion
|
Video Available to all JSM Registered Attendees. Please login to view.
|
